Author(s):
Sk. Arifa Begum, K. Aryani
Email(s):
arifashaik2007@gmail.com
DOI:
10.52711/0974-360X.2023.00518 
Address:
Sk. Arifa Begum1*, K. Aryani2
1Department of Pharmaceutics, KVSR Siddhartha College of Pharmaceutical Sciences, Siddhartha Nagar, Vijayawada, Andhra Pradesh, India.
2Department of Pharmaceutics, Chalapathi Institute of Pharmaceutical Sciences, Chalapathi Nagar, Lam, Guntur, Andhra Pradesh, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 7,
Year - 2023
ABSTRACT:
Buccal mucoadhesive patches of losartan potassium were formulated using hydroxypropyl methyl cellulose grades - K4M, K15M, K50M and Eudragit L100 polymers by the method of solvent casting. The prepared formulations were characterized for mechanical and physicochemical parameters like thickness, surface pH, uniformity of weight, swelling index, folding endurance, percentage moisture loss, drug content, in vitro dispersion and in vitro residence time. Further, in vitro drug release study was performed with the use of freshly prepared egg membrane as the semi-permeable membrane. The best formulation (F6) exhibited higher percentage of drug release 97.26%±0.41 at the end of 8 h. The sustained release of losartan potassium was found to be attained up to 8 h duration.
Cite this article:
Sk. Arifa Begum, K. Aryani. Development and Evaluation of Buccal Mucoadhesive patches of Losartan Potassium. Research Journal of Pharmacy and Technology 2023; 16(7):3151-6. doi: 10.52711/0974-360X.2023.00518
Cite(Electronic):
Sk. Arifa Begum, K. Aryani. Development and Evaluation of Buccal Mucoadhesive patches of Losartan Potassium. Research Journal of Pharmacy and Technology 2023; 16(7):3151-6. doi: 10.52711/0974-360X.2023.00518 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-7-15
REFERENCES:
1. Hoogstrate AJ, Verhoef JC, Tuk B, Pijpers A, van Leengoed LA, Verheijden JH, Junginger HE, Boddé HE. In vivobuccal delivery of fluorescein isothiocyanate - dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs. Journal of Pharmaceutical Sciences. 1996; 85(5): 457-460.doi: 10.1021/js950129k.
2. Patel KV, Patel ND, Dodiya HD, Shelat PK. Buccal bioadhesive drug delivery system: an overview. International Journal of Pharmaceutical and Biological Archive. 2011; 2(2): 600-609.
3. Jagadeeshwar Reddy R, Maimuna AA. Comprehensive review on buccal drug delivery system. American Journal of Alzheimer's Disease and Other Dementias. 2013; 1(3): 300-312.
4. Aungst A. Permeability and metabolism as barriers to transmucosal delivery of peptides and proteins. In: D.S.Hsieh (Ed.), Drug permeation enhancement. Theory and applications. Marcel Dekker, New York, 1994, 323-343.
5. https://go.drugbank.com/drugs/DB00678
6. Lippert C, Ling J, Brown P, Burmaster S, Eller M, Cheng L, Thompson R, Weir S. Mass balance and pharmacokinetics of MDL 16,455A in healthy male volunteers. Pharmaceutical Research. 1995; 12: S-390.
7. Khanna R, Agarwal SP and Ahuja A. Preparation and evaluation of mucoadhesive buccal films of clotrimazole for oral candida infections. Indian Journal of Pharmaceutical Sciences. 1997; 59: 299-305.
8. Merina A, Shajan A, Feba J, Haritha HP, Anu A, Elessy A, Dibyalochan M. Design and in-vitro evaluation of anagliptin buccal patch. Research Journal of Pharmacy and Technology. 2020; 13(8):3837-3842.
9. Arifa Begum Sk, Sravya AHLB, Deepika BGD, Naga Manasa G, Srujana M, Uma V, Lakshmi Tejeswari S, Padmalatha K. Formulation and evaluation of fexofenadine buccal mucoadhesive patches. Research Journal of Pharmacy and Technology. 2018; 11(11): 4892-4898.
10. Kumara SS, Shobha RS, Agaiah GB. Development, in-vitro and ex-vivo evaluation of muco-adhesive buccal patches of candesartan cilexetil. Research Journal of Pharmacy and Technology. 2019; 12(6): 3038-3044.
11. Maheswara RD, Madhusudhana CC, Dastagiri RY, Komali P,Divya SB, Sandhya RS. Formulation and Evaluation of fast dissolving buccal patches of tenofovir disoproxil fumarate. Research Journal of Pharmacy and Technology. 2021; 14(1):225-230.
12. Sussman GL, Mason J, Compton D, Stewart J, Richard N. The efficacy and safety of fexofenadine hcl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 1999; 104(1): 100-106.
13. Torrado JJ and Augsberger LL. Tableting of multi-particulate modified release systems. in: pharmaceutical dosage forms – tablets vol. 2. rational design and formulation(AugsbergerLL and Hoag SW. Ed.). 2008, 3rd Ed., Informa Healthcare, London, Pg. No. 509-533.
14. Sarojini S, Manavalan R, Priyadarsini S. Study of effect of solubility of drug on the release behaviour from buccal films of a hydrophilic polymer. Research Journal of Pharmacy and Technology. 2010; 3(1): 227-230.